Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

How The EU’s AI Act Offers Regulatory Sandbox Solutions For Medtech Manufacturers

Executive Summary

Are ‘regulatory sandboxes’ the answer to addressing complexities that will inevitably arise when the EU’s AI Act has been adopted and overlaps with the EU’s medtech regulations? This topic was examined by the European Commission at the recent International Medical Device Regulators Forum in Berlin.

You may also be interested in...



EU AI Act Regulatory Overlap “Likely To Persist”: Expert Presents Solutions For Dual Conformity

Regulatory overlap with the MDR and IVDR is likely to persist in the finalized AI Act text. However thorough preparation by medtech companies and the use of regulatory sandboxes could help address the need for dual conformity, reports lawyer Elizabethann Wright. 

Policy Misalignment Is Harming AI Development, Experts Say

Experts lamented the lack of consensus standards for AI medical devices, which they said could pose harm to innovators.

What Changes To The AI Act Would Benefit Medtech Most?

With the European Commission’s AI Act now in the final negotiation phase, industry bodies MedTech Europe and COCIR have outlined several areas where the draft text could be altered to optimize the potential of AI in health care.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT148347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel